Pulmonary Hypertension

Team: ¹Michelle Bartolo, ¹Amanda Colunga, ¹Mansoor Haider, ¹Mette Olufsen, ²Megan Chambers, ³Naomi Chesler, ⁴Nicholas Hill

Affiliations: ¹NC State University, ²Virginia Military Institute,³UC Irvine, ⁴University of Glasgow

Recent Publications:

1. Numerical predictions of shear stress and cyclic stretch in pulmonary hypertension due to left heart failure
   M Bartolo, MU Qureshi, M Colebank, N Chesler, MS Olufsen
   Biomechanics and Modeling in Mechanobiology, 2022
2. A multiscale model of vascular function in chronic thromboembolic pulmonary hypertension
   M Colebank, MU Qureshi, S Rajagopal, R Krasuski, MS Olufsen
   Integrative Cardiovascular Physiology and Pathophysiology, 2022
3. Structural and hemodynamic properties in murine pulmonary arterial networks under hypoxia-induced pulmonary hypertension
   M Chambers, M Colebank, MU Qureshi, R Clipp, MS Olufsen
   Journal of Engineering in Medicine, 2020

Overview:
Pulmonary hypertension (PH) is defined by an elevated blood pressure in the pulmonary arteries, leading to right ventricular dysfunction and alterations in typical oxygen exchange in the lungs. There are five main etiologies of PH, including PH due to left heart impairment (group II), PH due to lung disease, such as COPD and hypoxia (group III), and chronic thromboembolic PH (group IV). PH leads to remodeling in large and small arteries as well as arterioles, which changes both the structure and function of the pulmonary vasculature. Using mathematical modeling, our group investigates how both local and systems-level changes in hemodynamic parameters impact pressure, cardiac output, and heart function in patients with PH. Our long-term goal is to use mathematical modeling to monitor disease progression in PH patients in a non-invasive manner and further understand the underlying disease mechanism.

Video:

Click here to watch an overview!

Click here to return to our general research page!